Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Study: Pharmacokinetics of Oral Cyanocobalamin Formulated with SNAC

Originally published by Elsevier Journals on 24 May 2011, this white paper outlines an open-label, randomised, single-dose, parallel-group study of the pharmacokinetics of oral cyanocobalamin formulated with Sodium N-[8-(2-hydroxy benzoyl) amino] caprylate (SNAC).

Vitamin B12 deficiency may be caused by inadequate dietary intake or by conditions that result in malabsorption. Usually in the form of cyanocobalamin, crystalline vitamin B12 is administered parenterally or orally for the treatment of deficiency states.

Intramuscular administration is widely accepted as a treatment method and oral B12 supplements are also used but are considered less reliable.

More About This Company

Development Update

Novo Nordisk announced the European Commission (EC) has granted marketing authorisation for Rybelsus®, (oral semaglutide),...